Fig. 1From: C6-ceramide treatment inhibits the proangiogenic activity of multiple myeloma exosomes via the miR-29b/Akt pathwayThe characteristics of exosomes derived from MM cells treated with C6-cer. a Representative plots showing the size/concentration distribution of the secreted exosomes isolated from MM cells (OPM2 and RPMI-8226) treated with C6-cer tested by NTA 300; b The western blot analysis was performed to assess the level of CD63, which is the exosomal maker. All the experiments were performed in triplicatesBack to article page